Kathleen M. Castro

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Amylou C. Dueck, Tito R. Mendoza, Sandra A. Mitchell et al. · JAMA Oncology · 2015 · 1K citations · Full text

Pharmacy, Oncology, Outcomes Research +13

Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Antonia V. Bennett, Amylou C. Dueck, Sandra A. Mitchell et al. · Health and Quality of Life Outcomes · 2016 · 128 citations · Full text

Pharmacy, Health Informatics, Oncology +14

Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting Report

Michelle Mollica, Ashley Wilder Smith, Emily S. Tonorezos et al. · JNCI Journal of the National Cancer Institute · 2021 · 107 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +16

Allogeneic Lymphocytes Induce Tumor Regression of Advanced Metastatic Breast Cancer

Michael Bishop, Daniel H. Fowler, Donna Marchigiani et al. · Journal of Clinical Oncology · 2004 · 104 citations · Full text

Medicine, Immunology, Oncology +17

Stakeholder perspectives on implementing the National Cancer Institute’s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Deborah Watkins Bruner, Laura J. Hanisch, Bryce B. Reeve et al. · Translational Behavioral Medicine · 2011 · 92 citations · Full text

Medicine, Oncology, Clinical Informatics +16